Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
4.160
-0.040 (-0.95%)
At close: Dec 4, 2025, 4:00 PM EST
4.440
+0.280 (6.73%)
After-hours: Dec 4, 2025, 7:55 PM EST
LIXT Market Cap
LIXT has a market cap or net worth of $23.73 million as of December 4, 2025. Its market cap has increased by 559.15% in one year.
Market Cap
23.73M
Enterprise Value
21.35M
1-Year Change
559.15%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since November 25, 2020, LIXT's market cap has decreased from $47.40M to $23.73M, a decrease of -49.94%. That is a compound annual growth rate of -12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 24.00M | 421.74% |
| Dec 31, 2024 | 4.60M | -13.21% |
| Dec 29, 2023 | 5.30M | -37.65% |
| Dec 30, 2022 | 8.50M | -48.17% |
| Dec 31, 2021 | 16.40M | -59.20% |
| Dec 31, 2020 | 40.20M | -15.19% |
| Nov 25, 2020 | 47.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.46B |
| Johnson & Johnson | 494.75B |
| AbbVie | 397.64B |
| UnitedHealth Group | 294.18B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.90B |
| Abbott Laboratories | 219.64B |